F M Investments LLC Makes New Investment in LivaNova PLC (NASDAQ:LIVN)

F M Investments LLC bought a new stake in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 58,031 shares of the company's stock, valued at approximately $2,687,000. F M Investments LLC owned about 0.11% of LivaNova as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Russell Investments Group Ltd. boosted its position in LivaNova by 17.1% during the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock worth $70,000 after purchasing an additional 219 shares during the period. Central Pacific Bank Trust Division lifted its stake in LivaNova by 21.2% during the fourth quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company's stock worth $191,000 after purchasing an additional 720 shares during the period. Vestcor Inc bought a new stake in shares of LivaNova in the 4th quarter worth about $204,000. Captrust Financial Advisors bought a new position in shares of LivaNova in the third quarter valued at about $217,000. Finally, Inceptionr LLC acquired a new stake in shares of LivaNova in the 4th quarter valued at $217,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages recently weighed in on LIVN. StockNews.com upgraded shares of LivaNova from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, March 25th. Mizuho dropped their price objective on LivaNova from $70.00 to $60.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 26th. Wolfe Research lowered shares of LivaNova from an "outperform" rating to a "peer perform" rating in a research report on Wednesday, February 26th. Needham & Company LLC restated a "buy" rating and set a $64.00 price target on shares of LivaNova in a report on Monday, March 17th. Finally, Stifel Nicolaus reduced their price target on LivaNova from $72.00 to $60.00 and set a "buy" rating on the stock in a research report on Wednesday, February 26th. Two equities research analysts have rated the stock with a hold rating, five have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus price target of $61.17.

LivaNova Stock Up 1.4 %

LIVN stock traded up $0.50 during midday trading on Wednesday, hitting $35.30. The stock had a trading volume of 158,303 shares, compared to its average volume of 624,340. LivaNova PLC has a 52-week low of $32.48 and a 52-week high of $64.48. The firm has a market cap of $1.92 billion, a price-to-earnings ratio of 84.05 and a beta of 0.90. The business has a 50-day moving average of $40.84 and a two-hundred day moving average of $47.08. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.